We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




New Antibiotics Aim to Block Quorum Sensing

By Biotechdaily staff writers
Posted on 12 Jul 2006
Researchers have shown that an alpha-adrenergic antagonist could block the quorum sensing receptor (QseC receptor) of Escherichia coli O157:H7, which prevents the pathogenic bacteria from colonizing and infecting the intestinal tract.

Quorum sensing is a cell-to-cell signaling mechanism in which bacteria secrete hormone-like compounds called autoinducers. More...
When these auto-inducers reach a certain threshold concentration, they interact with bacterial transcriptional regulators, thereby regulating gene expression.

Investigators at the University of Texas Southwestern Medical Center (Dallas, USA) had previously shown that the AI-3 quorum-sensing system is the mechanism by which E coli O157:H7 interacts with the eukaryotic hormones epinephrine/norepinephrine. This interaction activates the transcription of virulence genes in the bacteria.

In the current study, the investigators worked with a rabbit model to evaluate the ability of alpha and beta-adrenergic antagonists to interfere with the bacterial quorum sensing system. They reported in the June 27, 2006, online edition of the Proceedings of the [U.S.] National Academy of Sciences that the competitive nonselective alpha-adrenergic receptor antagonist. phentolamine bound to the E coli QseC receptor and prevented it from sensing the environmental signals that normally would have caused it to express its virulence genes.

"This receptor is found in many pathogens, so we can use this knowledge to design specific antagonists to block bacterial infections,” said senior author Dr. Vanessa Sperandio, assistant professor of microbiology at the University of Texas Southwestern Medical Center. "Overuse of antibiotics has led bacteria to develop resistance to antibiotics, so a novel type of therapy is needed.”



Related Links:
University of Texas Southwestern Medical Center

Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
New
Nucleic Acid Purification Instrument
QIAsymphony Connect
New
Silver Member
Vitamin D Assay
EZ Vitamin D Assay
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image Credit: Shutterstock

New Insights Into Fetal DNA Could Improve Non-Invasive Prenatal Testing

Non-invasive prenatal testing is widely used to screen pregnancies for genetic conditions by analyzing DNA fragments in maternal blood. Although it offers a safer alternative to invasive procedures such... Read more

Microbiology

view channel
Image: Schematic overview of the CRISPR-Assisted Nanodroplet-pairing Platform for Differential Identification of NTM (CANDI). The platform combines broad-range amplification using conserved regions of the 16S and 23S rRNA genes with species-specific CRISPR recognition. Fluorescence-coded CRISPR droplets are paired with sample droplets containing amplified products, enabling multiplexed target recognition and signal decoding (Image Credit: Yiwen Yang, Jingsong Xu, Dakang Xu)

Nanodroplet CRISPR Technology Supports Rapid, Multiplexed Mycobacterial Identification

Mycobacterial infections are difficult to diagnose because closely related species can have different clinical and therapeutic implications. Nontuberculous mycobacteria (NTM) are increasingly recognized... Read more

Technology

view channel
Image: The laser-based photoacoustic spectroscopy setup consists of a Mid-IR laser equipped with three QCL modules covering wavelengths from 5.6 μm to 12.9 μm, two silver coated mirrors (SCM), a dichroic mirror (DM) with a transmittance of 90%, a thermal power sensor head (PM) to monitor the output laser power, a mechanical chopper (MC) for frequency modulation and a CEPAS-detector with a self-designed swab holder (SH). (Credit: Graunke, T., Scholz, T., Pieniak, M. et al. Scientific Reports (2026). https://doi.org/10.1038/s41598-026-68298-9)

Laser-Based Swab Analysis Shows Promise for Detecting Disease-Linked Odor Patterns

Disease-related changes in volatile organic compounds can alter body odor, producing measurable patterns in exhaled breath and bodily fluids. Current analytical methods can be complex, time-consuming,... Read more

Industry

view channel
Image: TruVerus is designed to deliver a broad menu of routine blood tests from a small blood sample on a single, automated benchtop platform (Photo courtesy of Truvian Health)

Collaboration Advances Automated Benchtop Platform for Routine Blood Testing

Routine blood testing is central to clinical decision-making, but access can vary across laboratory and healthcare settings. Broader use of automated benchtop platforms may help integrate testing more... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.